Stock screenerAll disclosures →
EDGAR →
CSTL
Conviction 22HealthcareScan · Thu, Jun 25, 2026CSTL$22.88+3.41%
ResistanceSupportVol 14Insider sell4
4
4
4
6
Vol MA14 329.43K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price22.88
Change+3.41%
Gap+2.06%
Rel volume0.78×
Avg volume342.62K
Avg $ vol7.21M
SMA 2021.05
SMA 5021.79
SMA 20028.68
Price vs 50+5.00%
Price vs 200-20.23%
MA stackmixed
50/200 cross—
Supertrendup · 19.77
RSI (14)61
MACD hist0.29
MACD cross—
Stoch %K / %D99 / 88
ADX (14)12
+DI / −DI28 / 18
RSI divergence—
MACD divergence—
ATR %+4.30%
ADR %4.23%
52w high43.04
52w low14.65
From 52w high-46.85%
Above 52w low+56.14%
New 52w highNo
SqueezeFired
Bollinger width13.71%
%B1.13
Donchian pos98.97%
Donchian high22.91
Donchian low19.51
AVWAP (52w high)25.86
vs AVWAP high-11.54%
AVWAP (52w low)27.39
vs AVWAP low-16.47%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d0.78×
Avg vol (14d)329.43K
Avg vol (20d)342.62K
Avg $ vol (20d)7.21M
Market cap693.8M
RS 3m (vs SPY)-25.00%
RS 6m (vs SPY)-51.65%
RS line new highNo
Trend template3/8
Technical rank40.2
1 week+12.96%
1 month+16.18%
3 months-9.48%
6 months-44.73%
1 year+19.39%
YTD-40.65%
P/E-28.72
P/B1.50
P/S2.02
P/FCF24.49
EPS-0.8300
Div yield—
ROE-5.24%
ROA-4.41%
Debt/Eq0.02
Current6.75
EV/EBITDA-313.93
Gross margin15.39%
Net margin-7.02%
Rev growth3.66%
EPS growth-232.41%
Price target42.43
Target upside85.49%
Analyst ratingBuy
Institutional98.76%
Ent. value640.1M
Revenue83.68M
Net income-14.52M
Gross profit19.79M
Free cash flow28.33M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out30.33M
Employees942
ListedThu, Jul 25, 2019
Free float28.32M
Float %93.5%
Short interest1.48M
Days to cover3.8d
Short volume23.4%
Squeeze score29 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast−$0.38 · 1 est
Last EPS vs est−$0.49 vs −$0.56
Last surprise+12.5% beat
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank40.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance23.94
Support18.02
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CSTL
No recent disclosed trades by Congress in CSTL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CSTL · 1 buy · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Oelschlager Kristen M Chief Operating Officer · Common Stock · 2026-06-16 | Sell | 8.59K | $178K | 2026-06-16 | 2026-06-18 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-15 | Sell | 1.36K | $28K | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Stock option (right to buy) · 2026-06-15 | Exercise | 550 | — | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-15 | Exercise | 550 | $1K | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-15 | Sell | 550 | $11K | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-15 | Sell | 1.15K | $24K | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-15 | Sell | 278 | $6K | 2026-06-15 | 2026-06-17 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-01 | Sell | 6.21K | $130K | 2026-06-01 | 2026-06-03 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Common Stock · 2026-06-01 | Sell | 278 | $6K | 2026-06-01 | 2026-06-03 |
MAETZOLD DEREK J Pres. & Chief Exec. Officer · Stock option (right to buy) · 2026-06-01 | Exercise | 204 | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in CSTL · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.